Urogen Pharma Drug Patent Portfolio
Urogen Pharma's Family Patents
Clinical Trials
Recent Clinical Trials by Urogen Pharma:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer | UroGen Pharma Ltd. | NA |
RECRUITING
(Sep 1, 2026)
| PHASE3 |
| A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer | UroGen Pharma Ltd. | NA |
ACTIVE NOT RECRUITING
(Apr 1, 2026)
| PHASE3 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List